Board of Claris Lifesciences approves proposal for voluntary delisting from BSE
At meeting held on 16 December 2017
The Board of Claris Lifesciences at its meeting held on 16 December 2017 has approved proposal for voluntary delisting of equity shares of the Company from the BSE.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content